Skip to main content

Nasdaq News

Is Gilead Sciences an Acquisition Target?

6 years 8 months ago
Gilead Sciences' (NASDAQ: GILD) latest earnings report and full-year outlook didn't exactly inspire confidence among investors last week. The biotech heavyweight told the investing community a week ago today that its top line will likely dip yet again this year thanks to fallin

Validea John Neff Strategy Daily Upgrade Report - 2/11/2020

6 years 8 months ago
The following are today's upgrades for Validea's Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth that trade at a discount relative to their earnings growth and dividend yield.
Checked
16 minutes 35 seconds ago
This feed is responsible for generating the rss feed related to the topic latest article
Subscribe to Nasdaq News feed